hengrui glp 1 China Challenges GLP-1 Leaders γ € Kailera licensed a portfolio of obesity therapies from China's Jiangsu Hengrui, including a Phase 3 GLP-1 candidate that delivered up to 10.9% average weight loss at 44 π ORAL GLP-1 UPDATE π
Pay in 4 interest-free payments of $5.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13

























